Option Care Health (NASDAQ:OPCH) Posts Quarterly Earnings Results

Option Care Health (NASDAQ:OPCH) issued its earnings results on Thursday. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.37 by $0.03, FiscalAI reports. Option Care Health had a return on equity of 18.17% and a net margin of 3.64%.The business had revenue of $1.35 billion during the quarter, compared to analysts’ expectations of $1.39 billion. During the same period in the prior year, the business earned $0.40 EPS. The business’s revenue for the quarter was up 1.3% compared to the same quarter last year. Option Care Health updated its FY 2026 guidance to 1.820-1.920 EPS.

Here are the key takeaways from Option Care Health’s conference call:

• The company revised full-year net revenue guidance down to $5.675B–$5.775B (?1% growth at midpoint) and now expects an approximately $55 million gross profit headwind from the CID/Stelara patient reset.
• Acute therapies and IG?neuro were strong in Q1 (acute revenue grew high single digits) and ambulatory clinic utilization improved (visits +14% YoY; 34% of nursing visits in suites/clinics), supporting higher-margin growth vectors.
• Management kept full-year adjusted EBITDA guidance at $480M–$505M and adjusted EPS at $1.82–$1.92 despite the revenue cut, citing cost reductions, variable cost discipline, and sequential momentum beginning in Q2.
• Q1 saw a doubling of benefit reverification/reauthorization work that extended into late March, causing a larger-than-expected chronic patient census decline and some patient losses to competitors or self-administration that will take time to recover.
• Financial flexibility improved with net leverage at 2.2x, the revolver expanded to $850M, >$17M of share repurchases in Q1, and continued focus on organic investment and targeted M&A to support recovery and growth.

Option Care Health Stock Down 1.5%

Shares of NASDAQ OPCH traded down $0.30 during mid-day trading on Friday, reaching $20.03. 6,371,673 shares of the company were exchanged, compared to its average volume of 2,412,801. The company has a quick ratio of 0.96, a current ratio of 1.64 and a debt-to-equity ratio of 0.85. The stock has a market cap of $3.14 billion, a price-to-earnings ratio of 15.65, a P/E/G ratio of 1.14 and a beta of 0.68. Option Care Health has a 1 year low of $18.01 and a 1 year high of $36.80. The firm has a 50-day moving average of $29.15 and a 200 day moving average of $30.69.

Trending Headlines about Option Care Health

Here are the key news stories impacting Option Care Health this week:

• Positive Sentiment: EPS/operating results had some upside or in?line elements (reported EPS near/above consensus per several services), which is a partial offset to the headline weakness. MarketBeat earnings note
• Neutral Sentiment: Option Care issued FY?2026 EPS guidance of $1.82–$1.92 (roughly in line with consensus) and provided a slide deck and conference call — limiting clarity on margin/profit trajectory but not eliminating uncertainty. GlobeNewswire press release
• Negative Sentiment: The company missed revenue estimates for Q1 ($1.35B reported vs. ~$1.40B consensus) and lowered full?year revenue guidance to $5.7–$5.8B (vs. ~$5.9B consensus), a direct driver of the share decline. Yahoo Markets article
• Negative Sentiment: Multiple law firms have announced investigations into Option Care for potential securities?law violations following the Q1 release, increasing legal and disclosure risk for shareholders. Block & Leviton alert Levi & Korsinsky alert
• Negative Sentiment: Analysts have reacted: TD Cowen cut its price target from $37 to $23 and placed a “hold”, and Bank of America downgraded OPCH from “buy” to “neutral” (PT $22), reflecting increased caution from the sell?side. Benzinga note
• Negative Sentiment: Shares experienced heavier-than-normal volume and a sharp intraday decline after the results and guidance cut, indicating weak near?term investor sentiment and heightened selling pressure. Seeking Alpha coverage

Institutional Investors Weigh In On Option Care Health

Hedge funds have recently made changes to their positions in the stock. Mariner LLC lifted its stake in shares of Option Care Health by 7.1% during the 4th quarter. Mariner LLC now owns 10,060 shares of the company’s stock worth $321,000 after purchasing an additional 663 shares during the last quarter. Quantinno Capital Management LP lifted its stake in shares of Option Care Health by 34.7% during the 2nd quarter. Quantinno Capital Management LP now owns 8,396 shares of the company’s stock worth $273,000 after purchasing an additional 2,162 shares during the last quarter. PharVision Advisers LLC purchased a new stake in Option Care Health in the third quarter valued at about $271,000. Quadrant Capital Group LLC raised its stake in Option Care Health by 151.7% in the fourth quarter. Quadrant Capital Group LLC now owns 8,238 shares of the company’s stock valued at $262,000 after buying an additional 4,965 shares during the last quarter. Finally, Boothbay Fund Management LLC purchased a new stake in Option Care Health in the third quarter valued at about $243,000. 98.05% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

Several equities research analysts have weighed in on OPCH shares. Jefferies Financial Group reiterated a “buy” rating and issued a $37.00 target price on shares of Option Care Health in a report on Tuesday, January 13th. Morgan Stanley upped their target price on Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a report on Tuesday, January 13th. Stephens set a $30.00 target price on Option Care Health in a report on Friday. Citigroup reiterated an “outperform” rating on shares of Option Care Health in a report on Tuesday, January 13th. Finally, UBS Group lowered their target price on Option Care Health from $45.00 to $39.00 and set a “buy” rating for the company in a report on Friday. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating and three have assigned a Hold rating to the stock. According to MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $32.00.

Option Care Health Company Profile

Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.

Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.